Montag A & Associates Inc
Source: SEC Form 13F · as of Mar 2026Montag A & Associates Inc holds 16 biotech & pharma companies tracked by BioSniper, totaling $1.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
16
Total value held
$1.2M
BioSniper AIPage context preserved
Prepared research question
What matters most for GILEAD SCIENCES, INC. (GILD)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| GILDGILEAD SCIENCES, INC. | 3,471 | $484K |
| ONCBeOne Medicines Ltd. | 750 | $223K |
| VKTXViking Therapeutics, Inc. | 5,013 | $163K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 2,232 | $124K |
| REGNREGENERON PHARMACEUTICALS, INC. | 137 | $106K |
| SNYSanofi | 898 | $43K |
| NKTRNEKTAR THERAPEUTICS | 250 | $18K |
| JAZZJazz Pharmaceuticals plc | 80 | $15K |
| GRFSGrifols S.A. | 1,477 | $12K |
| SLXNSilexion Therapeutics Corp | 3,000 | $4K |
| OGNOrganon & Co. | 554 | $3K |
| INSMINSMED Inc | 16 | $3K |
| BMRNBIOMARIN PHARMACEUTICAL INC | 34 | $2K |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 5 | $2K |
| NUVLNuvalent, Inc. | 8 | $793 |
| QUREuniQure N.V. | 5 | $81 |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.